Thermo Fisher Scientific Inc. (TMO) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-04 (expected, time not announced). EPS estimate 7.12, revenue estimate 12.84B.
Over the last 12 reports the stock moved 4.9% on average (either way), rising 5 times and falling 7. EPS beat estimates 12 of 12 times; revenue 11 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-21 | 6.68 | 6.40 | +4.4% | 12.14B | 11.95B | -1.6% |
| Q2 FY2026 | 2026-07-23 | 6.03 | 5.72 | +5.4% | 11.99B | 11.71B | +7.9% |
| Q1 FY2026 | 2026-04-23 | 5.44 | 5.25 | +3.6% | 11.01B | 10.86B | -8.6% |
| Q4 FY2025 | 2026-01-29 | 6.57 | 6.45 | +1.9% | 12.22B | 11.95B | -4.8% |
| Q3 FY2025 | 2025-10-22 | 5.79 | 5.50 | +5.3% | 11.12B | 10.92B | +2.5% |
| Q2 FY2025 | 2025-07-23 | 5.36 | 5.23 | +2.5% | 10.86B | 10.68B | +11.1% |
| Q1 FY2025 | 2025-04-23 | 5.15 | 5.10 | +1.0% | 10.36B | 10.23B | -1.9% |
| Q4 FY2024 | 2025-01-30 | 6.10 | 5.94 | +2.7% | 11.40B | 11.28B | +5.2% |